Y Mabs Therapeutics Stock Market Value
| YMAB Stock | USD 4.67 0.06 1.27% |
| Symbol | YMAB |
Y mAbs Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Y MAbs. If investors know YMAB will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Y MAbs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.67) | Revenue Per Share | Quarterly Revenue Growth 0.134 | Return On Assets | Return On Equity |
The market value of Y mAbs Therapeutics is measured differently than its book value, which is the value of YMAB that is recorded on the company's balance sheet. Investors also form their own opinion of Y MAbs' value that differs from its market value or its book value, called intrinsic value, which is Y MAbs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Y MAbs' market value can be influenced by many factors that don't directly affect Y MAbs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Y MAbs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Y MAbs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Y MAbs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Y MAbs 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Y MAbs' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Y MAbs.
| 12/14/2024 |
| 03/14/2025 |
If you would invest 0.00 in Y MAbs on December 14, 2024 and sell it all today you would earn a total of 0.00 from holding Y mAbs Therapeutics or generate 0.0% return on investment in Y MAbs over 90 days. Y MAbs is related to or competes with Revolution Medicines, Black Diamond, Passage Bio, Bluebird Bio, Mersana Therapeutics, Zentalis Pharmaceuticals, and Travere Therapeutics. Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercializatio... More
Y MAbs Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Y MAbs' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Y mAbs Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.31) | |||
| Maximum Drawdown | 16.0 | |||
| Value At Risk | (6.65) | |||
| Potential Upside | 3.78 |
Y MAbs Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Y MAbs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Y MAbs' standard deviation. In reality, there are many statistical measures that can use Y MAbs historical prices to predict the future Y MAbs' volatility.| Risk Adjusted Performance | (0.29) | |||
| Jensen Alpha | (0.96) | |||
| Total Risk Alpha | (0.59) | |||
| Treynor Ratio | (0.92) |
Y mAbs Therapeutics Backtested Returns
Y mAbs Therapeutics shows Sharpe Ratio of -0.37, which attests that the company had a -0.37 % return per unit of risk over the last 3 months. Y mAbs Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Y MAbs' Mean Deviation of 2.57, standard deviation of 3.23, and Market Risk Adjusted Performance of (0.91) to validate the risk estimate we provide. The firm maintains a market beta of 1.23, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Y MAbs will likely underperform. At this point, Y mAbs Therapeutics has a negative expected return of -1.2%. Please make sure to check out Y MAbs' accumulation distribution, and the relationship between the potential upside and day median price , to decide if Y mAbs Therapeutics performance from the past will be repeated at future time.
Auto-correlation | 0.74 |
Good predictability
Y mAbs Therapeutics has good predictability. Overlapping area represents the amount of predictability between Y MAbs time series from 14th of December 2024 to 28th of January 2025 and 28th of January 2025 to 14th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Y mAbs Therapeutics price movement. The serial correlation of 0.74 indicates that around 74.0% of current Y MAbs price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.74 | |
| Spearman Rank Test | 0.72 | |
| Residual Average | 0.0 | |
| Price Variance | 0.18 |
Y mAbs Therapeutics lagged returns against current returns
Autocorrelation, which is Y MAbs stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Y MAbs' stock expected returns. We can calculate the autocorrelation of Y MAbs returns to help us make a trade decision. For example, suppose you find that Y MAbs has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Y MAbs regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Y MAbs stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Y MAbs stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Y MAbs stock over time.
Current vs Lagged Prices |
| Timeline |
Y MAbs Lagged Returns
When evaluating Y MAbs' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Y MAbs stock have on its future price. Y MAbs autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Y MAbs autocorrelation shows the relationship between Y MAbs stock current value and its past values and can show if there is a momentum factor associated with investing in Y mAbs Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Y mAbs Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Y MAbs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Y Mabs Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Y Mabs Therapeutics Stock:Check out Y MAbs Correlation, Y MAbs Volatility and Y MAbs Alpha and Beta module to complement your research on Y MAbs. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Y MAbs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.